“showed a trend”

Although all markers showed a trend for association with survival (Training p<0.20), stromal TEM-1 expression as well as stromal vessel Col I and HIF2α were the only biomarkers to validate in the univariate setting.

- 0.987), HDL-cholesterol (0.953, 95% CI; 0.911 - 0.993), LDL-cholesterol (1.021, 95% CI; 0.998 - 1.042), Fontain IV (1.761; 95% CI; 0.726 - 4.979), LEAI in all segments (1.086, 95% CI; 0.971 - 1.175), LECS in all segments (1.633, 95% CI; 1.349 - 1.977), and log CCS (14.316, 95% CI; 4.657 - 44.009) showed a trend (P < 0.20) toward an association with multivessel-CAD.

54.4%; P = 0.2) and underlying comorbidities, though the ESRD group showed a trend towards a higher prevalence of type 2 diabetes mellitus (16.0 vs. 9.5; P = 0.2) and arterial hypertension (24.0 vs. 15.5%; P = 0.2).

Although pseudoislets showed a trend of reduction in first/second phase SI (mean ± SD = 1.73 ± 0.6) compared with fresh islets ( P = 0.20), the ratio was higher compared with cultured‐intact islets ( P < 0.05, Fig. 2 C).

Several independent variables showed a trend of association ( P < 0.2) in the Spearman rank analysis.

All variables that showed a trend towards an association ( P < 0.2) were included in the logistic regression analysis.

While CDKN2A loss showed a trend towards shorter PFS (4.9 vs. 9.7 months; p = 0.2), CDKN2B loss was significantly associated with worse outcomes (PFS 4.8 vs. 11.0 months; p = 0.03).

Analysis of differences in pharmacotherapy showed a trend toward more frequent use of an aldosterone antagonist in Group I (60.0% vs. 38.7%; p = 0.2), but no differences were found regarding the use of β-blockers (100% vs. 97.1%; p = 0.254) and angiotensin-converting-enzyme inhibitors/angiotensin II receptor blockers (91.1% vs. 91.4%; p = 0.96) between both groups.

ECD analysis at 20 weeks showed a trend toward higher values in the emricasan group (n = 68) compared with the vehicle group (n = 35) (2067 ± 19 cells/mm 2 vs. 2019 ± 32 cells/mm 2 , respectively; p = 0.200).

However, because the total positive work reduction during T L was 0.230 ± 0.094 J/kg, the total positive work during T L + T FCA = [0%, 64%] showed a trend of reduction by 0.088 ± 0.108 J/kg ( p < 0.2).

Results derived from IHC conducted on FFPEs derived from 7 PM vs 13 MBM showed a trend of increased infiltration of CD45+ immune cells in PM vs MBM ( P = 0.2; Supplementary Fig. 1A ).

The variables that showed a trend for an association (p<0.2) in the bivariate analysis were added in the regression model, and those with statistically significance association (p< 0.05) were maintained in the model.

We considered parameters that showed a trend (with P < 0.2) toward affecting ovarian parameters in the subsequent multivariate logistic regression model.

Comparing the interval from PrTu diagnosis to LiMe between the high and low miRNA-21 expression group showed a trend towards faster development of LiMe (p = 0.20; Fig 2b ) with higher miRNA-21 levels in the PrTu.

Although low SLCO1B3 expression showed a trend towards shorter overall survival, this correlation was not statistically significant (p = 0.2).

Specifically, blood-derived env sequences from control animals showed a trend towards greater divergence (0.45%) than env sequences derived from the blood plasma of vaccinees (0.35%, P = 0.2).

Notably, FID was comparably prevalent (26.4%–34.4%) across all stages of hematological malignancies, whereas AID showed a trend for higher prevalence in stage IV disease (stage I–II: 5.4%, stage III: 6.2%, stage IV: 11.4%, P = 0.20).

Moreover, the rates of N 2 fixation showed a trend towards higher activity with a decreasing nitrate flux, albeit this trend was relatively noisy ( R 2 = 0.50, p < 0.2; Supplementary Fig. 9g ).

However, exposure to BDE-99, PCB-180, and Σ 3 PCB showed a trend of association ( P < 0.2) when considering unweighted UniFrac distances, indicating possible differences in rare taxa.

Looking at the LGE extent % in HCM patients who remained in SR (11±12%) compared to those who presented with AF at initial diagnosis (16±16%) or during follow-up (17±18%) showed a trend towards more LGE (16±16%, p=0.2 and 17±18%, p=0.1, respectively).

Morning treatment ( n = 158) showed a trend toward improved overall survival vs. afternoon ( n = 79); the median survival was 158 vs. 79 days ( p = 0.20, HR = 0.84, CI 95% 0.84–0.91).

Moreover, only wine showed a trend towards a protective effect for dementia when comparing current drinkers with never drinkers (RR 0.67, 95% CI 0.48 to 0.94; p = 0.2) or light-to-moderate drinker versus none (RR0.58, 95% CI 0.39 to 0.87; p = 0.196), among other types of alcoholic beverages.

The reported events were fewer in the canagliflozin studies, and the treatment effect showed a trend towards a reduction of SAE AKIs (OR 0.72 [95% CI 0.43–1.20], p = 0.20).

5A ), while the suppressive capacity of Tregs on proliferation showed a trend with demethylation (r = 0.4, p = 0.2, Fig. 5B , n = 13).

Latency to onset in rats that became diabetic was similar in the three groups, and for this reason, the Kaplan Meyer plot ( Figure 4A ) of the three groups showed a trend that did not reach statistical significance (p<0.2).